Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthopediatrics (KIDS) Change in Receivables (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Change in Receivables for 10 consecutive years, with $1.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Change in Receivables rose 355.48% to $1.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $9.4 million, a 97.22% increase, with the full-year FY2025 number at $9.4 million, up 97.22% from a year prior.
  • Change in Receivables was $1.1 million for Q4 2025 at Orthopediatrics, up from -$3.1 million in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $9.9 million in Q2 2025 to a low of -$3.2 million in Q4 2023.
  • A 5-year average of $1.4 million and a median of $296500.0 in 2022 define the central range for Change in Receivables.
  • Peak YoY movement for Change in Receivables: surged 100200.0% in 2023, then plummeted 622.86% in 2025.
  • Orthopediatrics' Change in Receivables stood at -$250000.0 in 2021, then plummeted by 533.6% to -$1.6 million in 2022, then crashed by 99.12% to -$3.2 million in 2023, then skyrocketed by 86.4% to -$429000.0 in 2024, then skyrocketed by 355.48% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Change in Receivables are $1.1 million (Q4 2025), -$3.1 million (Q3 2025), and $9.9 million (Q2 2025).